Sort
85,873 grants matching “alzheimers”
Pharmacology Of Stimulus Memory And Habit Formation
$985,315Mortimer Mishkin · National Institute Of Mental Health · ZIA · FY2013 · MH
Establishing the optimal frequency of dance movement for neurocognitive and physical outcomes in people at risk of Alzheimer's disease
$985,060Christina E Hugenschmidt · Wake Forest University Health Sciences · R01 · FY2025 · AG
Integrating Imaging-based Infrastructure into the INCLUDE Data Hub
$985,000Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2024 · HL
Administrative Core
$984,649Lisa C Silbert · Oregon Health & Science University · P30 · FY2025 · AG
Long Life Family Study: Columbia University
$984,549Stephanie Ann Cosentino · Columbia University Health Sciences · U01 · FY2016 · AG
Disaggregation of Toxic Protein Oligomers in Brain with ElectromagneticTreatment
$984,357Edward Culver Goodwin · Neuroem Therapeutics, Inc. · R44 · FY2023 · AG
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$984,329Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Hippocampal interneurons in novel memory formation in health and Alzheimer's disease
$984,291Annabelle Catherine Singer · Georgia Institute Of Technology · RF1 · FY2025 · AG
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease
$984,151Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
UC DAVIS ALZHEIMERS DISEASE CENTER CORE
$984,141University Of California Davis · P30 · FY2000 · AG
Biomolecular Recognition and Binding Mechanisms
$984,067Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Biofluid Core
$984,055Adam L Boxer · Mayo Clinic Rochester · U19 · FY2024 · AG
Epidemiology of Aging and Dementia - Autopsy Research
$984,013Lon Ray White · Kuakini Medical Center · U01 · FY2008 · AG
Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease
$983,932Paul Gregor · Gismo Therapeutics, Inc. · R44 · FY2022 · AG
Dietary protection against APOE4 phenotypes in aging and Alzheimer's
$983,833Christian J Pike · University Of Southern California · R01 · FY2024 · AG
Vanderbilt Alzheimer's Disease Research Center
$983,793Angela L. Jefferson · Vanderbilt University Medical Center · P20 · FY2023 · AG
Olera - Online Platform to Increase Access to Personalized Educational and Professional Assistance for AD/ADRD Caregivers
$983,732Tokunbo Falohun · Olera Inc. · R44 · FY2022 · AG
Tau oligomer platform validation using lead series candidate in htau mice
$983,729James G. Moe · Oligomerix, Inc · R44 · FY2019 · AG
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics
$983,554Shelly L Gray · Kaiser Foundation Research Institute · U19 · FY2024 · AG
Novel, Orally-Available Prodrugs for Alzheimer's Disease
$983,466Francis X Tavares · Resilio Therapeutics, Llc · R44 · FY2017 · AG
Preclinical Alzheimer Disease and Driving
$983,337Catherine M Roe · Washington University · R01 · FY2017 · AG
An H/F/X/Y Fast-MAS NMR Probe Particularly for Alzheimer's and Cancer Research
$983,296Francis David Doty · Doty Scientific, Inc. · R44 · FY2021 · GM
GENETIC EPIDEMIOLOGY OF ALZHEIMER'S DISEASE IN TWINS
$983,268Duke University · R01 · FY2002 · AG
Independent and Dependent Life in the Elderly
$982,992David A. Snowdon · University Of Kentucky · R01 · FY2006 · AG
Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
$982,970Francis David Doty · Doty Scientific, Inc. · R44 · FY2025 · GM